Khan, Tanisha Tabassum SaykaAshraf, Anushey2023-08-082023-08-0820222022-10ID 17346033http://hdl.handle.net/10361/19353Cataloged from PDF version of thesis.Includes bibliographical references (pages 57-72).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.Lung cancer is one of the leading causes of cancer related deaths. The malignancy is marked by a bleak prognosis and poor clinical result, owing primarily to advanced stage at diagnosis, imposing a significant cost on public health worldwide. Lung cancer genomic analysis revealed genetic variety and complexity, as well as multiple targetable oncogenic driver changes. These molecular profiling efforts have enabled the potential of molecularly tailored medicines to be realized. In this review, an insight has been provided on the current landscape of targeted therapy for lung cancer treatment, the obstacles associated with this approach, and tactics that could be used to overcome those challenges.72 pagesenBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Lung cancerAntibodiesTargeted therapyVaccinesLung cancer--TreatmentThesis